PHOTREXA CROSS-LINKING KIT

Riboflavin 5-phosphate ophthalmic · Glaukos Corporation

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PHOTREXA CROSS-LINKING KIT, covering 2016-04-15 to 2025-02-07. Get the full timeline:

Most recent: FDA Approved: PHOTREXA CROSS-LINKING KIT — Supplemental Application (Glaukos Corporation)